Print
Email
Print Edition Stories
MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges
Amicas Inc., a health information technology company, said Monday it agreed to be acquired by private equity firm Thoma Bravo LLC in a deal worth about $217 million in cash.
Boston-based Amicas entered into a definitive agreement on December 24 and the deal is expected to close in the first quarter of 2010.
Under terms of the agreement, Amicas shareholders will receive $5.35 in cash for each share they hold. Thoma Bravo, which has offices in Chicago and San Francisco, is paying a 21 percent premium over the stock’s previous close of $4.42.
“The agreement with Thoma Bravo provides an attractive all-cash valuation to our shareholders, and we look forward to completing the transaction under the terms of the agreement as expeditiously as possible,” Dr. Stephen Kahane president, CEO, and chairman of Amicas, said in a statement.
Amicas’ board of directors unanimously approved the agreement and resolved to recommend that Amicas shareholders adopt it.
Amicas can seek other offers from third parties for 45 days beginning Dec. 24.
Earlier this year, Amicas, which develops radiology and medical imaging software, has announced an agreement to acquire Emageon Inc., an Alabama hospital and health care technology service provider for about $39 million in a stock buyout.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
